about
Bone Marrow Cells in Suppressing Leukemic Cell Growth.The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization.Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization.Death receptor 3 is essential for generating optimal protective CD4⁺ T-cell immunity against Salmonella.Transplantation treatment of spinal cord injury patients.Cell therapy of comatose states.Cell therapy of brain stroke.CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.Soluble factor and cell-cell interaction in cytostasis induced by bone marrow cellsTumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative studyA role for interferon-gamma and transforming growth factor-beta in erythroid cell-mediated regulation of nitric oxide production in macrophages[Effects of revolving electric fields of industrial frequency on blood system of laboratory animals][Suppressor effect of immature erythroid cells on B-cell proliferation][A role of the transforming growth factor-beta in suppression of B-cell blastogenesis mediated by erythroid cells][Comparative study of the antineoplastic cytostatic and natural suppressive activity of bone marrow cells][Production by activated lymphocytes of mediators increasing the antitumor cytostatic activity of bone marrow cells][Production of mediators enhancing antineoplastic cytostatic activity of bone marrow cells by activated lymphocytes]Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responsesEradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulationRequirement for CD70 in CD4+ Th cell-dependent and innate receptor-mediated CD8+ T cell primingCutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs
P50
Q30914359-F51E21C7-757E-4CB5-ABC4-22539BD1D040Q41832095-C55527D4-B38C-47B4-A3EA-CE3147FEC79CQ41903916-756AB44F-BCAC-4B42-9DCC-B98B42D96424Q43891437-4C0E3B1C-99B3-4972-9F93-B204E247B014Q45349247-0A36CF09-9FD7-4284-96CF-B7D084FDC6F2Q46070701-C0F60C76-BFDC-4BF3-BF8E-D866C79A4C15Q48127763-094285DB-845D-46E5-9C95-CC3A61369E40Q48236149-A28489F6-C753-49C3-ABDC-9B5C4EF7EAE4Q48787915-AA20A759-C6DF-465F-8ED0-595317DFB3DEQ50964324-8EA4A724-1BF1-45D4-AF38-B6903DAABD48Q57681591-3654B2F9-449E-41ED-AE2E-D373A3A9AF4FQ57681623-44EE4630-E075-467A-BFD5-D1DA28D7101FQ57681639-3083BCE0-3DDD-436D-A1FD-07A67E938F5DQ72166009-082A9F90-BA6C-441B-B7B8-919363E3970BQ73489272-7F24C9A7-8729-4BB2-8E5C-24F455BC371CQ74204836-3A49E64E-2BF7-4CCE-BE29-C4F5C57986F2Q74665860-5A552B0F-0ECC-4968-B0BB-6552BBA40047Q74847898-24ED4959-0BD6-4E19-92D8-902D29E9B211Q77218788-9B95CC8A-3E80-447E-961D-9ECD8395F22AQ78759402-C8D52940-EB81-499E-8C61-2FD167402A77Q79803065-6D9B29B1-538E-4014-B710-9C6387ECD6CAQ80142465-CD3450C9-D5B6-46A0-9317-532F3F8616D9Q81040825-2677AB00-F8BD-41CF-B218-32625C07593F
P50
description
researcher
@en
wetenschapper
@nl
name
Taraban VIa
@en
Taraban VIa
@nl
type
label
Taraban VIa
@en
Taraban VIa
@nl
prefLabel
Taraban VIa
@en
Taraban VIa
@nl
P106
P31
P496
0000-0001-7713-091X